Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

GSK plc (GSK, GSK.L) announced the European Commission has approved Jemperli in combination with chemotherapy for first-line ...

LOS ANGELES - The FDA unveiled a proposal Tuesday to require front-of-package nutrition labels on most packaged foods, a major step in combating chronic diseases. The labels, called "Nutrition ...

iTeos Therapeutics anticipates this year an interim readout from its Phase III GALAXIES Lung-301 trial of its anti-TIGIT antibody belrestotug in combination with GlaxoSmithKline's anti-PD-1 monoclonal ...

The FDA's rule proposal would, if finalized, require U.S. food manufacturers to add a front-of-package (FOP) nutrition label on most packaged food goods produced in the United States. Related ...

MANILA, Philippines — The move of the Department of Agriculture (DA) to remove brand labels and premium classifications on imported rice is a “shallow attempt” at addressing price ...